Lab results in under 30 minutes, right in your clinic.
Genalyte builds point-of-care lab testing systems that deliver 90% of clinical lab results in under 30 minutes without leaving the clinic. Its flagship Merlin platform is a fully automated, onsite blood testing machine using silicon photonic microring sensor technology. The company submitted the Merlin device to the FDA for premarket clearance in 2025 and is part of the MedTech Innovator accelerator.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account